Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CD4+ T-cell Epitope (Tetanus Toxoid-Derived) (TT-derived CD4+ T-cell epitope)
- Target
- TT-derived CD4+ T-cell epitope
- Molecular classification
- Peptide, MHC Class II-restricted epitope
01
Overview
CD4+ T-cell epitopes derived from tetanus toxoid are short linear peptides processed from this widely used vaccine antigen. They are essential triggers for adaptive immunity following vaccination due to their ability to activate helper functions via interaction with MHC-II-restricted receptors on human CD4+ lymphocytes. Their identification has enabled improved understanding and engineering of effective vaccines suitable for broad population coverage due to their frequent cross-HLA reactivity ("universal" status).
- Other names
- Tetanus toxoid CD4+ epitopeTT epitopeTetanus toxoid-derived T-helper cell epitope
02
Mechanism of action
Epitope presented on MHC class II molecules activates CD4+ T cells, leading to T cell proliferation, cytokine secretion, B cell help and development of immunological memory.
03
Biological functions
T cell activationCytokine productionB cell helpImmunological memoryAdaptive immunity
04
Disease associations
Infection (Clostridium tetani)Vaccine response
05
Safety considerations
Potential for altered immunogenicity due to epitope mutationsEpitope-specific immune tolerance
06
Interacting drugs
Tetanus toxoid vaccine
2 more in the full profile.
07
Biomarkers
Frequency of TT-specific CD4+ T cellsCytokine production upon TT stimulation (e.g., IFN-gamma, IL-5)MHC Class II binding affinity
Beyond the preview
Go deeper on CD4+ T-cell Epitope (Tetanus Toxoid-Derived) (TT-derived CD4+ T-cell epitope).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CD4+ T-cell Epitope (Tetanus Toxoid-Derived) (TT-derived CD4+ T-cell epitope).